GI
TOI icon

GAMMA Investing’s The Oncology Institute TOI Stock Holding History

GAMMA Investing’s Portfolio TOI Stock Details TOI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$342 Hold
63
– – ﹤0.01% 4033
2026
Q1 		$193 Sell
63
-97
-61% -$297 ﹤0.01% 4059
2025
Q4 		$570 Buy
+160
New +$593 ﹤0.01% 3896

Other funds holding TOI

PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
BCP
Blackhawk Capital Partners Thiensville, Wisconsin $306M AUM 25.68% 1-Year Est. Return
FA
Fermata Advisors Sonoma, California $495M AUM 20.19% 1-Year Est. Return
MWA
Miller Wealth Advisors Ridgeway, Colorado $279M AUM 82.16% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
CAL
Capital Advisors Ltd Shaker Heights, Ohio $991M AUM 19.82% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HFS
Hughes Financial Services Herndon, Virginia $755M AUM 20.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GAMMA Investing's TOI Position: Q2 2026 in Review

GAMMA Investing held its The Oncology Institute (TOI) position steady in Q2 2026 at 63 shares worth $342. The position accounts for ﹤0.01% of the portfolio, ranked #4033.

GAMMA Investing first reported a position in TOI in Q4 2025 and has held it in 3 quarters since. The position peaked at $570 in Q4 2025. 10 funds tracked by Wall St. Rank hold TOI as of Q2 2026.

  • GAMMA Investing held 63 shares of The Oncology Institute worth $342 as of Q2 2026.
  • GAMMA Investing left its The Oncology Institute share count unchanged in Q2 2026.
  • The Oncology Institute made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #4033 holding.
  • GAMMA Investing first reported a position in The Oncology Institute in Q4 2025 and has held it in 3 quarters since.
  • GAMMA Investing's The Oncology Institute position peaked at $570 in Q4 2025.
  • 10 funds tracked by Wall St. Rank held The Oncology Institute as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.